NCT06259838Completed
Oral Cavity Squamous Cell Carcinoma and Readmission: Rates, Causes, and Risk Factors.
Source: ClinicalTrials.gov · Last updated 14 Feb 2024
Brief summary (registry, in English)
We sought to comprehend the rates and causes of unplanned hospital readmission within 60 days following oral cancer surgery
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 93 (actual)
- First submitted
- 7 Feb 2024
- Start date
- 1 Jan 2023
- Primary completion date
- 27 Dec 2023
- Lead sponsor
- Abdulsalam Alqutub
- Diseases
- Head and neck cancer, Childhood cancers
- NCT number
- NCT06259838
What you commit to
- Study type: Observational
- Participants enrolled: 93
- From 1 Jan 2023 to the primary completion date, 27 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- significant missing data
Who the study is looking for
- all patient underwent oral cancer surgery in king Abdulaziz University hospital
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| King Abdulaziz University Hospital Coordinator of this site? Confirm its status | Jeddah | Saudi Arabia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.